Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours. This strategic funding supports the growth and diversification of Organigram’s…
Author of the article:
Article content
- The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and diffe…